Cardiovascular comorbidities in atopic dermatitis: Potential implications for the use of Janus kinase inhibitors

J Am Acad Dermatol. 2023 Dec;89(6):1296-1298. doi: 10.1016/j.jaad.2023.08.029. Epub 2023 Aug 19.

Authors

J Mark Jackson¹, Amanda Althoff², Lawrence Rasouliyan², Stacey Long², Carla L Zema³

Affiliations

¹ University of Louisville, Division of Dermatology, 501 S. Second St., Louisville, Kentucky. Electronic address: jacksonjmark@gmail.com.
² OMNY Health, 75 5th Street NW, Centergy Building, Suite 2090, Atlanta, Georgia.
³ Zema Consulting, 164 John Deere Way, Madison, Alabama.

PMID: 37604236
DOI: 10.1016/j.jaad.2023.08.029

No abstract available

MeSH terms

Comorbidity
Dermatitis, Atopic* / drug therapy
Dermatitis, Atopic* / epidemiology
Humans
Janus Kinase Inhibitors* / adverse effects

Substances

Janus Kinase Inhibitors